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Abstract
Background: The aim of this study was to investigate the usefulness of a triaxial accelerometer for the clinical
assessment of standing and gait impairment in ataxic patients quantitatively. Fifty-one patients with spinocerebellar
ataxia (SCA) or multiple system atrophy with predominant cerebellar ataxia (MSA-C) and 56 healthy control subjects
were enrolled. The subjects, with a triaxial accelerometer on their back, were indicated to stand for 30 s in four
different conditions (eyes opened or closed, and feet apart or together) and then to walk 10 m for a total of 12
times on a flat floor at their usual walking speed. In standing analysis, the degree of body sway was assessed. In
gait analysis, gait velocity, cadence, step length, step regularity (auto-correlation coefficient: AC), step repeatability
(cross-correlation coefficient) and the degree of body sway (The ratio of root mean square in each direction to the
root mean square vector magnitude: RMSR) were evaluated.
Results: The degree of body sway in each standing condition and all parameters in gait showed a significant
difference between the patients and control subjects. The AC and RMSR values, as well as the Scale for the
Assessment and Rating of Ataxia score, showed a strong correlation with disease duration.
Conclusions: Various parameters obtained by a triaxial accelerometer can be sensitive and objective markers for
the assessment and follow-up of standing and gait impairment in ataxic patients.
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Background
Spinocerebellar ataxia (SCA) and multiple system atro-
phy with predominant cerebellar ataxia (MSA-C) present
mainly with gait or truncal ataxia [1, 2]. There are no re-
liable biomarkers available for the assessment of cerebellar
ataxia; therefore, scales based on neurological examina-
tions such as the International Cooperative Ataxia Rating
Scale or Scale for the Assessment and Rating of Ataxia
(SARA) have been used widely for this purpose [3, 4].
SARA is easy to perform, but is not sufficiently sensi-
tive for the assessment of short-term interval changes or
of patients in the early stage of disease. In some cohort
studies for SCA, the SARA scores changed by at most 1
or 2 points a year [5–7]. If a more sensitive and objective
method of assessment is available, it will be of great
value for clinical trials of new drugs or an intervention
by intensive rehabilitation, because such clinical applica-
tions need a short-term assessment of their effectiveness.
For quantitative analysis of motor function, the useful-
ness of a triaxial accelerometer has been shown [8, 9]. A
triaxial accelerometer is a small and light device that is
not stressful for the subject, and can provide various
useful parameters [8–13]. This device has been ap-
plied to patients with some neurodegenerative disor-
ders such as Parkinson’s disease and Huntington’s
disease [11, 14–16]. However, there is no detailed re-
port on the analysis of standing and gait in patients
with SCA and MSA-C. The aim of this study was to
validate the usefulness of a triaxial accelerometer for
the assessment of standing and gait impairment in
ataxic patients.
Results
There was no significant difference for the gender
and age distribution between the patients and controls
(gender: p = 0.761, age: p = 0.200). Disease duration, SARA
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score and disease subtype for the patients enrolled are
summarized in Table 1.
Standing assessment
For standing, all 51 patients could maintain a standing
position in Stance 1 (the feet were apart and the eyes
were open), but 4 patients in Stance 2 (the feet were to-
gether and the eyes were open), 2 patients in Stance 3
(the feet were apart and the eyes were closed), and 14
patients in Stance 4 (the feet were together and the eyes
were closed) could not maintain the standing position
concerned. In all four stances, the horizontal acceler-
ation vector magnitude (the postural sway) of the pa-
tients was significantly greater than that of the control
subjects. The postural sway with eyes closed in each
stance was significantly greater than that with eyes
opened in both the patients and control subjects (Fig. 1).
Gait assessment
For gait analysis, 3 patients could not complete the 10-m
trial 12 times, therefore, the cross-correlation coefficient
(CC) could not be calculated for them. The auto-
correlation coefficient (AC) and the CC in the left-right
direction (Y axis) were not assessed because the acceler-
ation data in the Y axis were not sufficiently sensitive to
detect gait cycle and it was not appropriate to apply to the
auto-correlation method. The ratio of root mean square in
each direction to the root mean square vector magnitude
(RMSR) in the anterior-posterior direction (X axis) and
the vertical direction (Z axis) were not assessed because
the RMSR was considered to have an effective meaning
only in the Y axis [17]. All parameters measured in the test
were significantly different between the patients and con-
trol subjects. The level of significance was very high for all
parameters, except cadence (Fig. 2).
Correlation with disease duration
The total SARA score correlated well with disease dur-
ation (Table 2). In standing, the postural sway correlated
with disease duration only in the Stance 1. In gait, the
AC in the X axis and the RMSR in the Y axis, as well as
gait velocity and step length, were significantly corre-
lated with disease duration (Table 2).
Chronological change of the parameters
Eleven patients (spinocerebellar ataxia type 31 [SCA31],
4; cortical cerebellar ataxia [CCA], 2; MSA-C, 4; ataxia
associated with Hashimoto’s disease, 1) and 18 control
subjects were measured twice, with an interval of ap-
proximately 6 months (Fig. 3). The patient with ataxia
associated with Hashimoto’s disease was measured sev-
eral times before and after the initiation of therapy
(methylprednisolone pulse and oral corticosteroid). For
the patients, gait velocity, the AC and the RMSR were
evaluated because they were significantly correlated with
disease duration. Compared with the control subjects,
the AC values showed deterioration in all MSA-C pa-
tients. For the patients with CCA and SCA31, the deteri-
oration in each parameter was not so significant.
Conversely, the patient with ataxia associated with
Hashimoto’s disease showed an improvement in RMSR
at 1 month after the initiation of therapy. The SARA
score of gait deteriorated by 1 point in one MSA-C pa-
tient, while it improved by 1 point in Hashimoto's
Table 1 Characteristics of the subjects
Patients Controls





Male/female, n 24/27 28/28
Age, years 60.3 ± 10.4 (39–79) 57.2 ± 14.1 (31–85)
Disease duration, years 8.7 ± 6.5 (0–24) .
SARA score (total) 8.6 ± 3.6 (1–16)













aFamily history was supportive of autosomal dominant cerebellar ataxia
(ADCA), but genetic testing was not performed
Fig. 1 Boxplot of the postural sway in each stance with whiskers of
1.5 IQR. The circles are outliers. *p < 0.05, **p < 0.001, ***p < 0.0001
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disease patient. The SARA score of gait was unchanged
in the other patients over a period of approximately 6
months.
Discussion
Some devices such as force plates or stabilometer have
been used for the quantitative evaluation of ataxic
patients [18, 19]. Compared with those devices, a triaxial
accelerometer has several advantages: it is much smaller,
easy to handle, and does not interfere with the move-
ment of the subject or require much time for taking
measurements. Therefore, it is suitable for repeated
measurements to assess the chronological changes. In
addition, a triaxial accelerometer can measure through-
out a three-dimensional space and gain much more pa-
rameters regarding motor function than force plates or a
stabilometer.
In this study, we enrolled only ambulatory patients
with cerebellar ataxia who could stand or walk by them-
selves (approximate total SARA score < 15). Therefore,
they were relatively mild in the severity or at an early
stage of ataxia, although the disease subtypes were vari-
able. There is no curative therapy for SCA or MSA-C.
Any disease-modifying intervention, if available in the
future, will be more effective in the earlier stage of
disease. Therefore, a method will be needed to detect
subtle changes of the degree of ataxia in patients in
the early stage.
The data obtained during standing assessment showed
a significant difference between the patients and control
subjects in all stances. In addition, the postural sway was
more severe with eyes closed than with eyes open, and
the degree of difference was more conspicuous in the
patients than in the control subjects. More importantly,
the triaxial accelerometer could detect a clear difference
between the patients and control subjects even in the
Fig. 2 Boxplot of the parameters of gait analysis with whiskers of 1.5 IQR. a Velocity. b Cadence. c Step length. d Auto-correlation coefficient (AC)
in the X and Z axis. e Cross-correlation coefficient (CC) in X and Z axis. f The ratio of root mean square in each direction to the root mean square
vector magnitude (RMSR) in the Y axis. The circles are outliers. *p < 0.05, **p < 0.001, ***p < 0.0001
Table 2 Spearman's rank order correlation between disease
duration and each parameter
rho value p value
SARA (total) 0.35 0.012
Stance (postural sway)
Stance 1 0.31 0.025
Stance 2 0.27 0.070
Stance 3 0.24 0.096




Step length -0.34 0.011
AC in X axis -0.29 0.037
AC in Z axis -0.25 0.081
CC in X axis -0.14 0.330
CC in Z axis -0.21 0.161
RMSR in Y axis 0.51 <0.001
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easiest standing task (Stance 1). These findings were ba-
sically the same as those obtained using a stabilometer
[18], but a triaxial accelerometer can be applied more
easily to patients who are unable to walk at all, but only
can stand without any support.
In gait assessment, gait velocity and step length were
significantly different between the patients and control
subjects, but these parameters were probably affected by
several factors other than cerebellar ataxia including the
age, gender, and height of the subject [19]. Therefore,
parameters other than velocity or step length will be
needed to evaluate gait impairment. For this purpose,
AC, CC, and RMSR were calculated and assessed in this
study. Here we proposed CC as the original parameter
of gait. The CC showed the degree of similarity in every
6 pairs of the walking trials from the definition. There-
fore, we thought the CC represented gait repeatability.
We found a significant difference in the CC, as well as
in the AC and the RMSR, between the patients and con-
trol subjects. Although further study is needed to con-
firm the meaning of the CC in more detail, these
parameters obtained by the triaxial accelerometer could
be excellent markers for assessing gait disturbance in
ataxic patients.
The correlation between the SARA score and dis-
ease duration in ataxic patients was confirmed previ-
ously [4, 20], and such a correlation with disease duration
was also observed in the parameters obtained using the
triaxial accelerometer in this study. The AC (parameter
for step regularity) in the X axis and RMSR (that for the
degree of sway) in the Y axis values were significantly cor-
related with disease duration. These results suggested that
step regularity in the anterior-posterior direction and the
degree of sway in the left-right direction accounted for the
deterioration with disease duration. The efficacy of the
AC as a parameter for differentiating patients with
Parkinson’s disease from normal subjects has been re-
ported [11, 15], which was confirmed for patients with
cerebellar ataxia in this study. Furthermore, the correl-
ation with disease duration was also found in the postural
sway in Stance 1 (the feet were apart and the eyes were
open), which was completed by all the patients. Although
the degree of correlation in the postural sway was not as
much as other parameters, the postural sway could be one
of the useful parameters, especially for patients who could
not walk.
We suppose that the AC and the RMSR reflect the
chronological change of disease severity effectively. In
the patient with Hashimoto’s disease, her subjective
complaint improved after therapy. Consistent with this,
this improvement was detected objectively by the triaxial
accelerometer. Her AC value was unchanged by therapy
because it was initially similar to the values observed in
the control subjects, but her RMSR value improved. In
the patients with MSA-C, the AC values deteriorated
greatly during the follow-up period, indicating that step
regularity of the patients was affected progressively. The
SARA score of gait for a patient with MSA-C increased
Fig. 3 Chronological changes of the patients and control subjects. a Gait velocity. b Auto-correlation coefficient in the X axis. c The ratio of root
mean square in each direction to the root mean square vector magnitude (RMSR) in the Y axis
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during the follow-up period by 1 point, but the score of
the other MSA-C patient did not change. This suggests
the possibility that the AC obtained by a triaxial acceler-
ometer is a more sensitive indicator to detect the pro-
gression of gait ataxia, although the factors affecting the
AC value remain unclear. In contrast, the AC value did
not deteriorate in the patients with SCA31 and CCA. Al-
though the natural history of SCA31 and CCA has been
not revealed yet, both diseases are considered to have
a much more protracted clinical course than MSA-C.
The difference of the AC value between MSA-C and
SCA31/CCA patients is very likely to reflect that of
the rate of progression between these diseases. As the
number of patients in each disease subtype who were
measured twice was small, the comparison between
the subtypes might be preliminary. Further study of
the chronological changes in the AC and RMSR value
is needed to see the difference of progression between
the subtypes with cerebellar ataxia.
We have to state that there were some limitations
in this study. Firstly, we did not assess the AC and
CC in the Y axis probably because of a low sensitivity
to detect gait cycle in some subjects. One of the rea-
sons for this would be the lower sampling rate of the
instruments we used. The instrument which had
higher sampling rate (128Hz) was used in the report
which succeeded at obtaining the AC value in the Y
axis [12]. Secondly, we did not assess well how the
walking speed affected on other parameters. Although
the relationship between walking speed and AC was
unclear [12], that between walking speed and the root
mean square of acceleration in gait was clarified [9,
13]. To minimize the effect of gait velocity on mea-
sured accelerations as much as possible, RMSR was
proposed [17]. It would preferable that the result was
compared between the groups with the same walking
speed to minimize the effect of walking speed much
more, but it was difficult because the slowness of walking
speed itself was just a symptom in ataxic patients. RMSR
was originally used to compare hemiplegic patients with
healthy subjects [17], but the method may be applicable to
patients with other diseases in principle.
Conclusion
Not only gait velocity and step length but also the pa-
rameters obtained with the triaxial accelerometer clearly
discriminated the ataxic patients from the control sub-
jects. Among several parameters, the AC and RMSR in
gait analysis showed a strong correlation with disease
duration, and possibly changed chronologically along
with disease progression. A triaxial accelerometer can be
an excellent tool for the objective and quantitative evalu-
ation of cerebellar ataxia.
Methods
Subjects
Fifty-one patients clinically diagnosed with SCA or
MSA-C and 56 control subjects without gait impairment
were enrolled in this study (Table 1). All patients could
stand and walk by themselves, but some used a cane or
walker to avoid fall. Patients whose SARA score of gait
was more than 6 points or SARA score of stance was
more than 3 points were excluded, and patients who had
a comorbid condition with disorders such as cerebrovas-
cular or orthopedic disorders, that affects motor func-
tion were also excluded. The group of patients included
a female patient with Hashimoto’s disease who com-
plained mainly of unsteadiness on standing and gait. She
was diagnosed previously as SCA, but we considered her
ataxic symptoms were associated with Hashimoto’s dis-
ease based on her responsiveness to steroid therapy.
Some subjects (11 patients and 18 control subjects) were
measured twice with an approximately 6-month interval
to evaluate chronological changes.
When the subjects were recruited, they were provided
with all necessary information about the study and in-
formed consent was obtained from all subjects. This
study was approved by the Ethics Committee of Shinshu
University School of Medicine (No. 2667).
Instrumentation
A triaxial accelerometer (Jukudai Mate; Kissei Comtec
Co., Ltd., Matsumoto, Japan) was used. The device was
small (size, 55 mm × 80 mm, thickness, 10 mm), light
(weight, ~90 g) and easy to handle. It had a sampling
rate of 20 Hz. The range of detection was between -10G
and +10G (G: acceleration of gravity, 1G = 9.80665m/s2)
and the resolution power was 0.02G. The data acquired
by the device were analyzed by BIMUTAS II (Kissei
Comtec Co., Ltd., Matsumoto, Japan) which was devel-
oped for biological processing.
Measurements
The device was attached to the back and the median of
L3 of the subject by an elastic belt. SARA was evaluated
by the first or second author on the same day of the
measurements. The measurements were taken in the fol-
lowing order by more than three examiners. One of the
examiners was responsible only for time keeping, while
the others stood or walked along with the subject to pre-
vent fall.
Standing
In the assessment for standing, the subjects were indi-
cated to lower their arms to the sides of their body and
to stand for 30 s. The test was stopped when one foot or
both feet moved. The assessment was performed serially
in the following four different conditions: (1) the feet
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were placed 25 cm apart and the eyes were open (Stance 1);
(2) the feet were placed together and the eyes were open
(Stance 2); (3) the feet were placed 25 cm apart and the
eyes were closed (Stance 3); and (4) the feet were placed to-
gether and the eyes were closed (Stance 4). The subjects
who were not able to stand for 30 s during a stance were
excluded from the analysis of that stance.
Gait
After the measurement of standing, the subjects were
asked to walk on a flat floor at a speed they were com-
fortable with. The walking distance was 10 m. The walk-
ing test was repeated 12 times (6-times reciprocating
walk) consecutively. For subjects who found it difficult
to walk 12 times, the test was aborted at the end of the
third reciprocating walk. All subjects were instructed to
stop walking at 3 m beyond the end of the walkway dur-
ing each 10-m test. As the patients were often unstable
at the beginning and end of walking [21], the data at the
beginning and end of the test were eliminated and those
for 6.4 s from the middle part were used for gait analysis.
Parameters
The axes of the direction of acceleration were defined as
follows: X axis, anterior-posterior (front-back) direction;
Y axis, left-right (crosswise) direction; and Z axis, verti-
cal (head-foot) direction.
Standing
The degree of body sway in standing, as the horizontal
acceleration vector magnitude (postural sway) was calcu-
lated every 0.05 s. The mean value of the postural sway
for 30 s was used for the analysis, which represented the
degree of sway during standing.
Gait
The following parameters were taken: (a) velocity, (b) ca-
dence, (c) step length, (d) auto-correlation coefficient
(AC), (e) cross-correlation coefficient (CC), and (f ) The
ratio of root mean square in each direction to the root
mean square vector magnitude (RMSR). Velocity was
calculated by the time taken for each 10-m walking test,
and the mean of each value was used for the analysis.
Cadence, defined as steps per minute, was calculated
using the steps counted from the acceleration data and
walking time. Step length was calculated using velocity
and cadence. To compare the similarity of two different
functions mathematically, a cross-correlation function
was used. The cross-correlation function expressed the
similarity of two functions as a value from -1 to 1. It
used the convolution of functions to calculate the value.
Especially, the value of the cross-correlation function of
the two same functions was named the auto-correlation
function. Each value of the auto-correlation function is a
correlation coefficient between the raw acceleration data
and the data to be shifted at some sample points from
the same raw acceleration data. When the shifted sample
point is 0, the position is defined as the reference point.
A similar method to the auto-correlation function, called
the auto-correlation method, was used in gait analysis
[11, 12, 16]. From the processed acceleration data by the
auto-correlation method, the first coefficient peak next
to the reference point was defined as AC. The mean of
12 ACs was used for the analysis; this value represented
step regularity [11, 12]. As for the AC, by selecting the
acceleration data of every 6 pairs of the 12 walking trials
(1st measurement and 7th measurement, 2nd measure-
ment and 8th measurement, and so on), the value of the
cross-correlation function of each data pair was calcu-
lated. The maximum value in the cross-correlation func-
tion of each pair was defined as CC. The mean of 6 CCs
was used for the analysis. From the definition of CC, it
represented gait repeatability. A proportional relation-
ship has been shown between the root mean square of
acceleration acquired from an accelerometer fixed on
the body trunk and the square of gait velocity [9, 13]. To
eliminate the relation between measured accelerations
and gait velocity as much as possible, RMSR was pro-
posed [17]. The same method was adopted in this study.
The mean of 12 RMSRs was used for the analysis. The
RMSR represented the degree of sway during gait [17].
Statistical analysis
Statistical analysis was performed using R (Foundation for
Statistical Computing, Vienna, Austria). The assumption of
a normal distribution was assessed by the Kolmogorov-
Smirnov test. The independence of the gender ratio be-
tween the patients and control subjects were assessed by
the chi-square test. The difference of the mean age between
the patients and control subjects was assessed by T-test for
two independent groups. The difference in standing and
gait parameters between both groups was assessed by the
Wilcoxon rank sum test. The difference between the paired
data during standing was assessed by the Wilcoxon
signed rank test. The correlation between disease dur-
ation and the standing and gait parameters was
assessed by Spearman’s rank correlation coefficient. The
difference between the chronological changes in the con-
trol subjects was assessed by the paired T-test. The level
of significance was set at p < 0.05 in all tests.
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